Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
46 studies found for:    Open Studies | "Arthritis, Juvenile Rheumatoid"
Show Display Options
Rank Status Study
21 Unknown  Magnetic Resonance Imaging Follow-up on Temporomandibular Arthritis in Children With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Procedure: Steroid injection into the TMJs.
22 Recruiting A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
23 Recruiting A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
24 Recruiting Extension Study Evaluating the Safety and Efficacy of Subcutaneous RoActemra/Actemra Administration in Patients With Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra]
25 Not yet recruiting A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Golimumab;   Drug: Methotrexate
26 Recruiting Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Abatacept
27 Recruiting Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis
Condition: Juvenile Idiopathic Arthritis Associated Uveitis
Intervention: Drug: Tocilizumab
28 Recruiting A Study of Decreased Dose Frequency in Patients With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
29 Recruiting A Study of RoActemra/Actemra (Tocilizumab) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis, Rheumatoid Arthritis
Intervention: Drug: Tocilizumab [RoActemra/Actemra]
30 Recruiting Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
Condition: Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
Intervention: Biological: Abatacept
31 Unknown  The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
Conditions: Uveitis;   Arthritis, Juvenile Rheumatoid
Intervention: Drug: TNFR:Fc
32 Recruiting Pediatric Arthritis Study of Certolizumab Pegol
Condition: Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
Intervention: Drug: Certolizumab Pegol (CZP)
33 Unknown  Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Procedure: intra-articular steroid injection
34 Not yet recruiting "Medikidz Explain JIA Comic Book- Hebrew"
Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: reading comics booklet
35 Not yet recruiting ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
Condition: Systemic Juvenile Idiopathic Arthritis (SJIA)
Intervention: Drug: ACZ885 150 mg (Canakinumab)
36 Unknown  Use of Thermal and 3D Imaging to Quantify Arthritis
Conditions: Rheumatoid Arthritis;   Juvenile Rheumatoid Arthritis
Intervention: Other: 3D and thermal imaging
37 Not yet recruiting Biomarkers in Saliva in Children With Juvenil Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
38 Unknown  PRINTO (the Paediatric Rheumatology International Trials Organisation)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: methotrexate
39 Recruiting The CARRA Registry
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Mixed Connective Tissue Disease;   Juvenile Ankylosing Spondylitis;   Juvenile Dermatomyositis;   Localized Scleroderma;   Systemic Sclerosis;   Vasculitis;   Sarcoid;   Fibromyalgia, Primary;   Auto-inflammatory Disease;   Idiopathic Uveitis Idiopathic
Intervention:
40 Recruiting Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
Conditions: Chronic Hepatitis B;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis;   Juvenile Idiopathic Arthritis
Interventions: Drug: Entecavir;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results    Last Page
Indicates status has not been verified in more than two years